Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 431

1.

Is low-molecular-weight heparin safe for venous thromboembolism prophylaxis in patients with traumatic brain injury? A Western Trauma Association multicenter study.

Kwiatt ME, Patel MS, Ross SE, Lachant MT, MacNew HG, Ochsner MG, Norwood SH, Speier L, Kozar R, Gerber JA, Rowell S, Krishnakumar S, Livingston DH, Manis G, Haan JM.

J Trauma Acute Care Surg. 2012 Sep;73(3):625-8.

PMID:
22929493
2.

Effect of a dalteparin prophylaxis protocol using anti-factor Xa concentrations on venous thromboembolism in high-risk trauma patients.

Droege ME, Mueller EW, Besl KM, Lemmink JA, Kramer EA, Athota KP, Droege CA, Ernst NE, Keegan SP, Lutomski DM, Hanseman DJ, Robinson BR.

J Trauma Acute Care Surg. 2014 Feb;76(2):450-6. doi: 10.1097/TA.0000000000000087.

PMID:
24458050
3.

Chemical venous thromboembolic prophylaxis is safe and effective for patients with traumatic brain injury when started 24 hours after the absence of hemorrhage progression on head CT.

Saadeh Y, Gohil K, Bill C, Smith C, Morrison C, Mosher B, Schneider P, Stevens P, Kepros JP.

J Trauma Acute Care Surg. 2012 Aug;73(2):426-30. doi: 10.1097/TA.0b013e31825a758b.

PMID:
22846950
4.

Low-molecular-weight heparin prophylaxis 24 to 36 hours after degenerative spine surgery: risk of hemorrhage and venous thromboembolism.

Strom RG, Frempong-Boadu AK.

Spine (Phila Pa 1976). 2013 Nov 1;38(23):E1498-502. doi: 10.1097/BRS.0b013e3182a4408d.

PMID:
23873245
5.

Safety and efficacy of prophylactic anticoagulation in patients with traumatic brain injury.

Scudday T, Brasel K, Webb T, Codner P, Somberg L, Weigelt J, Herrmann D, Peppard W.

J Am Coll Surg. 2011 Jul;213(1):148-53; discussion 153-4. doi: 10.1016/j.jamcollsurg.2011.02.027. Epub 2011 Apr 3.

PMID:
21459632
6.

A retrospective analysis of the effectiveness of low molecular weight heparin for venous thromboembolism prophylaxis in trauma patients.

Gritsiouk Y, Hegsted DA, Schlesinger P, Gardiner SK, Gubler KD.

Am J Surg. 2014 May;207(5):648-51; discussion 651-2. doi: 10.1016/j.amjsurg.2013.12.010. Epub 2014 Jan 30.

PMID:
24560359
7.

Traumatic brain injury is associated with the development of deep vein thrombosis independent of pharmacological prophylaxis.

Reiff DA, Haricharan RN, Bullington NM, Griffin RL, McGwin G Jr, Rue LW 3rd.

J Trauma. 2009 May;66(5):1436-40. doi: 10.1097/TA.0b013e31817fdf1c.

PMID:
19430251
8.

Comparative effectiveness of low-molecular-weight heparin versus unfractionated heparin for thromboembolism prophylaxis for medical patients.

Rothberg MB, Pekow PS, Lahti M, Lindenauer PK.

J Hosp Med. 2012 Jul-Aug;7(6):457-63. doi: 10.1002/jhm.1938. Epub 2012 Apr 2.

PMID:
22473716
9.

Pharmacologic prophylaxis for venous thromboembolism and 30-day outcomes among older patients hospitalized with heart failure: an analysis from the ADHERE national registry linked to Medicare claims.

Kociol RD, Hammill BG, Hernandez AF, Klaskala W, Mills RM, Curtis LH, Fonarow GC.

Clin Cardiol. 2011 Nov;34(11):682-8. doi: 10.1002/clc.20986. Epub 2011 Nov 6.

10.

Safety and efficacy of heparin or enoxaparin prophylaxis in blunt trauma patients with a head abbreviated injury severity score >2.

Minshall CT, Eriksson EA, Leon SM, Doben AR, McKinzie BP, Fakhry SM.

J Trauma. 2011 Aug;71(2):396-9; discussion 399-400. doi: 10.1097/TA.0b013e31822734c9.

PMID:
21825943
11.

Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.

Kanaan AO, Silva MA, Donovan JL, Roy T, Al-Homsi AS.

Clin Ther. 2007 Nov;29(11):2395-405. Review.

PMID:
18158080
12.

Unfractionated heparin versus low-molecular-weight heparin for venous thromboembolism prophylaxis in trauma.

Jacobs BN, Cain-Nielsen AH, Jakubus JL, Mikhail JN, Fath JJ, Regenbogen SE, Hemmila MR.

J Trauma Acute Care Surg. 2017 Jul;83(1):151-158. doi: 10.1097/TA.0000000000001494.

PMID:
28426561
13.

Very early initiation of chemical venous thromboembolism prophylaxis after blunt solid organ injury is safe.

Murphy PB, Sothilingam N, Charyk Stewart T, Batey B, Moffat B, Gray DK, Parry NG, Vogt KN.

Can J Surg. 2016 Apr;59(2):118-22.

14.

What is the effect of low-molecular weight heparin for venous thromboembolism prophylaxis compared with mechanical methods, on the occurrence of hemorrhagic and venous thromboembolic complications in patients with intracerebral hemorrhage? A critically appraised topic.

O'Carroll CB, Capampangan DJ, Aguilar MI, Bravo TP, Hoffman-Snyder CR, Wingerchuk DM, Wellik KE, Demaerschalk BM.

Neurologist. 2011 Jul;17(4):232-5. doi: 10.1097/NRL.0b013e318222d6c0.

PMID:
21712672
16.

Thromboembolic prophylaxis in blunt traumatic intracranial hemorrhage: a retrospective review.

Depew AJ, Hu CK, Nguyen AC, Driessen N.

Am Surg. 2008 Oct;74(10):906-11.

PMID:
18942611
17.

International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer.

Farge D, Debourdeau P, Beckers M, Baglin C, Bauersachs RM, Brenner B, Brilhante D, Falanga A, Gerotzafias GT, Haim N, Kakkar AK, Khorana AA, Lecumberri R, Mandala M, Marty M, Monreal M, Mousa SA, Noble S, Pabinger I, Prandoni P, Prins MH, Qari MH, Streiff MB, Syrigos K, Bounameaux H, Büller HR.

J Thromb Haemost. 2013 Jan;11(1):56-70. doi: 10.1111/jth.12070. Review.

18.

Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery.

Rasmussen MS, Jørgensen LN, Wille-Jørgensen P.

Cochrane Database Syst Rev. 2009 Jan 21;(1):CD004318. doi: 10.1002/14651858.CD004318.pub2. Review.

PMID:
19160234
19.

The safety and efficacy of use of low-molecular-weight heparin in pediatric neurosurgical patients.

Gonda DD, Fridley J, Ryan SL, Briceño V, Lam SK, Luerssen TG, Jea A.

J Neurosurg Pediatr. 2015 Sep;16(3):329-34. doi: 10.3171/2015.1.PEDS14489. Epub 2015 Jun 12.

PMID:
26067336
20.

Thromboprophylaxis with low-molecular-weight heparin after cesarean delivery.

Blondon M, Perrier A, Nendaz M, Righini M, Boehlen F, Boulvain M, De Moerloose P.

Thromb Haemost. 2010 Jan;103(1):129-37. doi: 10.1160/TH09-06-0349. Epub 2009 Oct 26.

PMID:
20062923

Supplemental Content

Support Center